Intervention

PADN

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

3 shown

Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection FractionNCT07331220 · 2026-12-30

NOT_YET_RECRUITING

Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial HypertensionNCT03282266 · 2018-01-18

A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAHNCT02284737 · 2014-11-28

Common conditions

Pulmonary Arterial Hypertension2 Heart Failure With Preserved Ejection Fraction1

Leading sponsors

Nanjing First Hospital, Nanjing Medical University3

Trial status mix

COMPLETED1

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA2

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.